Maxim Group Issues Positive Forecast for Nutex Health (NASDAQ:NUTX) Stock Price

Nutex Health (NASDAQ:NUTX) had its price target raised by equities research analysts at Maxim Group from $45.00 to $50.00 in a research note issued to investors on Tuesday, MarketBeat Ratings reports. The brokerage presently has a “buy” rating on the stock. Maxim Group’s price objective suggests a potential upside of 53.33% from the stock’s previous close.

Separately, Benchmark increased their target price on Nutex Health from $30.00 to $45.00 and gave the stock a “buy” rating in a research report on Wednesday, August 21st.

Nutex Health Trading Down 13.2 %

Shares of Nutex Health stock opened at $32.61 on Tuesday. Nutex Health has a fifty-two week low of $4.16 and a fifty-two week high of $39.48. The business’s fifty day moving average is $23.19 and its two-hundred day moving average is $13.95. The company has a quick ratio of 1.55, a current ratio of 1.77 and a debt-to-equity ratio of 3.36. The firm has a market cap of $177.40 million, a PE ratio of -3.47 and a beta of 0.11.

Insider Buying and Selling

In related news, CFO Jon Christian Bates purchased 1,350 shares of the firm’s stock in a transaction on Thursday, August 22nd. The shares were bought at an average price of $21.46 per share, for a total transaction of $28,971.00. Following the acquisition, the chief financial officer now directly owns 2,277 shares in the company, valued at $48,864.42. This trade represents a 100.00 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available at this link. 38.52% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Nutex Health

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. International Assets Investment Management LLC acquired a new position in shares of Nutex Health in the 3rd quarter valued at about $188,000. Thompson Davis & CO. Inc. purchased a new position in Nutex Health in the third quarter valued at approximately $494,000. Finally, Essex Investment Management Co. LLC purchased a new position in Nutex Health in the third quarter valued at approximately $1,579,000. 5.32% of the stock is currently owned by institutional investors and hedge funds.

About Nutex Health

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.